$3.91
0.041.03%
al cierre: Aug 19, 5:00 PM EST
$3.95
0.04051.04%
After hour: 6:41 PM EST
Fulcrum Therapeutics Inc
FULCNASDAQ
Fusiones y adquisiciones: Slate Medicines, Inc. announced it will be merged with Fulcrum Therapeutics (FULC) on Monday, August 17, 2026
Fulcrum Therapeutics Earnings & Forecasts
Fulcrum Therapeutics (FULC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Fulcrum Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.22 | $-0.30 | $-0.31 | $-0.29 |
| Actual | $-0.34 | $-0.25 | $-0.31 | $-0.31 |
| Surprise | -54.5% | +16.7% | 0.00% | -6.90% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.11 | $-0.08 | $-0.24 | $-0.25 |
| Revenue | ||||
| Consensus | — | — | — | — |